Skip to main content
Download PDF
Download ePub
  • Research article
  • Open access
  • Published:

Preoperative hidden renal dysfunction add an age dependent risk of progressive chronic kidney disease after cardiac surgery

Journal of Cardiothoracic Surgery volume 14, Article number: 151 (2019) Cite this article

Abstract

Background

To study different value of estimated glomerular filtration rate with normal serum creatinine whether is a risk factor for hidden renal function of cardiac surgery outcomes.

Methods

A total of 1744 cardiac surgery patients with serum creatinine ≤1.2 mg/dL (female)/1.5 mg/dL (male) were divided into 3 groups: estimated glomerular filtration rate ≥ 90 mL/min/1.73 m2 (no renal dysfunction, n = 829), 60 ≤ estimated glomerular filtration rate < 90 mL/min/1.73 m2 (hidden renal dysfunction, n = 857), estimated glomerular filtration rate < 60 mL/min/1.73 m2 (known renal dysfunction, n = 58) and followed up for 3 years. Multivariate regression analyses for risk factors of postoperative acute kidney injury.

Results

The proportion of preoperative hidden renal dysfunction was 67.1% among patients ≥  65 years old and 44.1% among patients < 65 years old. Multivariate Cox regression analyses showed that for patients < 65 years, known renal dysfunction was a risk factor for postoperative acute kidney injury (P <  0.01) and progressive chronic kidney disease (P = 0.018), while hidden renal dysfunction was a risk factor for progressive chronic kidney disease (P = 0.024). For patients ≥  65 years, only known renal dysfunction was a risk factors for 3-year mortality (P = 0.022) and progressive chronic kidney disease (P <  0.01).

Conclusion

Hidden renal dysfunction was common in patients with normal serum creatinine for cardiac surgery, with a prevalence of 49.1%. For patients < 65 years old, hidden renal dysfunction was an independent risk factor for progressive chronic kidney disease.

Peer Review reports

Background

Preoperative renal dysfunction is a high risk factor for outcomes in cardiac surgery, not only for postoperative acute kidney injury (AKI), but also for in-hospital mortality and even long-term outcomes [1,2,3]. Renal dysfunction is mostly evaluated by serum creatinine (SCr), but scholars have noted that patients with normal SCr had estimated glomerular filtration rate (eGFR) values < 60 mL/min and called it “occult renal dysfunction”, which significantly increased the risk of renal replacement therapy (RRT), inpatient death and prolonged hospitalization after coronary artery bypass grafting (CABG) surgery [4, 5]. In the study of Volkmann et al., patients with plasma creatinine (PCr) ≤ 1.5 mg/dL who underwent CABG were divided into 2 groups, estimated creatinine clearance (eCrCl) ≥ 60 mL/min (normal renal function) or eCrCl < 60 mL/min (reduced renal function), respectively. The results showed that reduced renal function had a double risk of death, a longer total hospital stay and post-surgical hospital stay than those patients with normal renal function [6]. However, a considerable fraction of cardiac surgery patients may have normal SCr values and an eGFR under 90 mL/min/1.73 m2, but above 60 mL/min/1.73 m2, particularly since eGFR declines with age [7]. In the present retrospective, observational, single center study we analyzed whether patients with “normal” SCr and “hidden renal dysfunction” (60 ≤ eGFR < 90 mL/min) have an enhanced risk of complications after cardiac surgery especially focusing on age-related eGFR decline.

Methods

Patients

In this retrospective, observational study, we collected data from patients who underwent cardiac surgery and with preoperative SCr ≤ 1.2 mg/dL (female) / 1.5 mg/dL (male) in Shanghai Zhongshan Hospital between October 2012 and July 2013. Exclusion criteria were < 18 years old; preoperative SCr ≥  1.2 mg/dL (female) / 1.5 mg/dL (male) and received deep hypothermic circulatory arrest or heart transplantation. The Ethical Committee of Zhongshan Hospital affiliated to Fudan University approved the study (No. B2017–039) and written informed consent was obtained from all patients and our study was performed in accordance with the Declaration of Helsinki regarding the ethical principles for medical research involving human subjects.

Definitions and groups

Pre-operative hidden renal dysfunction was defined as SCr ≤ 1.2 mg/dL (female)/1.5 mg/dL (male) and 60 ≤ eGFR < 90 mL/min/1.73 m2. AKI was defined according to the KDIGO 2012 criteria as the absolute value of the SCr increase ≥  26.5 μmol/L within 48 h or an increase > 50% compared to the baseline values within 7 days, or a urine output < 0.5 mL/kg/h ≥ 6 h [8].

Progressive chronic kidney disease (CKD) was defined as CKD stages 4–5 (eGFR ≤  30 mL/min/1.73 m2) including End-stage renal disease (ESRD) (receive maintenance renal replacement therapy or renal transplantation). CKD was diagnosed according to the Kidney Disease: Improving Global Outcomes (KDIGO) 2002 criteria [9]. All enrolled patients were divided into three groups: eGFR ≥  90 mL/min/1.73 m2 (no renal dysfunction), 60 ≤ eGFR < 90 mL/min/1.73 m2 (hidden renal dysfunction) and eGFR < 60 mL/min/1.73 m2 (known renal dysfunction). Low cardiac output syndrome (LCOS) was diagnosed when patients had two or more of the following [10, 11]: (1) decreased systolic pressure > 20% of the basic preoperative value lasting ≥  2 h; (2) signs of impairment of body perfusion (cold extremities, lowered level of consciousness, or a combination of these signs) and lasting ≥  2 h; (3) need for at least three vasoactive drugs (dopamine, dobutamine, epinephrine or norepinephrine) or required an intra-aortic balloon pump (IABP). Intra-operative hypotension was defined as mean arterial pressure <  65 mmHg and lasting ≥  10 min. High dose of vasoactive agents was defined as need of at least three vasoactive drugs, or the dose of norepinephrine or epinephrine more than 0.3 μg/kg/min. All the patients were followed up for 3 years through telephone, e-mail and hospital visits until October 2016. The primary endpoint was all causes of mortality and progressive CKD.

Statistical analysis

Statistical analysis was conducted with SPSS Statistics for Windows (Version 22.0, SPSS Inc., Chicago, US). Normally distributed data are presented as means ± SD; groups were compared using two independent sample t-tests or ANOVA. Nonparametric data are expressed as medians (P25, P75). The Wilcoxon test was used to assess two dependent variables, a non-parametric Mann–Whitney test for independent variables, and a chi-squared test for group comparisons. Multivariate Logistic regression analysis was used to investigate the influence of multiple factors of AKI incidence. Multivariate Cox regression analysis was used to investigate the effects of multiple factors on 3-year mortality and progressive CKD. A P-value < 0.05 was considered to be statistically significant.

Results

Baseline characteristics

A total of 1744 patients were enrolled between October 2012 and July 2013. There were 47.53% (n = 829) in the eGFR ≥  90 mL/min/1.73 m2 group (no renal dysfunction), 49.14% (n = 857) in the 60 ≤ eGFR < 90 mL/min/1.73 m2 group (hidden renal dysfunction) and 3.33% (n = 58) in the eGFR < 60 mL/min/1.73 m2 group (known renal dysfunction) (Fig. 1).

Fig. 1
figure 1

Groupings of patients. Abbreviations: SCr, serum creatinine; eGFR, estimated glomerular filtration rate

Full size image

Ages in hidden renal dysfunction group was significantly higher than in the no renal dysfunction group. The preoperative blood urea nitrogen (BUN) and SCr and uric acid in the hidden renal dysfunction group was significantly higher than in the no renal dysfunction group, but significantly lower than in the known renal dysfunction group. The proportion of proteinuria and renal ultrasound abnormal in hidden renal dysfunction group was significantly lower than in the known renal dysfunction group. The incidence of intra-operative hypotension in hidden renal dysfunction group was significantly lower than in the known renal dysfunction group (Table 1).

Table 1 Baseline characteristics of patients with different degree of hidden renal dysfunction
Full size table

AKI incidence and 3-year outcomes

The AKI incidence of the overall patients was 34.29% (n = 598). There was no statistical difference of AKI incidence between the hidden renal dysfunction and no renal dysfunction group or known renal dysfunction group. The in-hospital mortality in the hidden renal dysfunction group was significantly higher than in the no renal dysfunction group. The 3-year mortality and incidence of progressive CKD in the hidden renal dysfunction group was significantly higher than in the no renal dysfunction group, but significantly lower than in the known renal dysfunction group (Table 2).

Table 2 AKI incidence and 3-year outcomes of patients with different degree of hidden renal dysfunction
Full size table

Age <  65 years

The AKI incidence was 31.19% (n = 423) of patients under the age of 65 years. There was no statistical difference of AKI incidence between the hidden renal dysfunction and no renal dysfunction group or known renal dysfunction group. The 3-year mortality in the hidden renal dysfunction group was significantly lower than in the known renal dysfunction group. The in-hospital mortality and incidence of progressive CKD in hidden renal dysfunction was significantly higher than in no renal dysfunction group (Table 2).

Age ≥ 65 years

The AKI incidence was 45.10% (n = 175) of patients > 65 years old. There was no statistical difference of AKI incidence between the hidden renal dysfunction and no renal dysfunction group or known renal dysfunction group. The 3-year mortality in the hidden renal dysfunction group was significantly lower than in the known renal dysfunction group. There was no statistical difference of in-hospital mortality and incidence of progressive CKD between the hidden renal dysfunction and no renal dysfunction group or known renal dysfunction group (Table 2).

Analysis of risk factors for postoperative AKI

Age < 65 years

Multivariate Logistic regression analysis showed that age, gender (male), hypertension, aorta surgery, CPB time, LCOS, preoperative eGFR < 60 mL/min/1.73 m2 and intraoperative hypotension were independent risk factors of AKI after cardiac surgery (Table 3).

Table 3 Multivariate logistic regression analysis for the risk factors of postoperative AKI
Full size table

Multivariate Cox regression analysis showed that age, diabetes, postoperative AKI, length of ICU stay were independent risk factors of 3-year mortality (Table 4), and age, diabetes, 60 ≤ eGFR < 90 mL/min/1.73 m2, eGFR < 60 mL/min/1.73 m2, postoperative AKI and length of ICU stay were independent risk factors of 3-year progressive CKD (Table 5).

Table 4 Multivariate cox regression analysis for the risk factors of 3-year mortality
Full size table
Table 5 Multivariate cox regression analysis for the risk factors of progressive CKD
Full size table

Age ≥ 65 years

Multivariate logistic regression analysis showed that age, gender (male), BMI, intraoperative hypotension and LCOS were independent risk factors of AKI after cardiac surgery (Table 3).

Multivariate Cox regression analysis showed that diabetes, length of ICU stay and eGFR < 60 mL/min/1.73 m2 were risk factors for 3-year mortality (Table 4) and age, diabetes, eGFR < 60 mL/min/1.73 m2 and length of ICU stay were independent risk factors of 3-year progressive CKD (Table 5).

Discussion

It is commonly accepted that preoperative renal dysfunction is a risk factor for AKI, in-hospital mortality or even long-term outcomes after cardiac surgery [12]. Also “occult renal insufficiency” defined as SCr ≤ 100 μm with CrCl ≤  60 mL/min with an incidence rate of up to 13% has been shown to be associated with RRT [13], which is in accordance with our findings, that for patients with normal SCr under the age of 65 years, preoperative eGFR < 60 mL/min/1.73 m2 was an independent risk factor for AKI. However, interestingly for patients over the age of 65 years, preoperative eGFR< 60 ml/min/1.73 m2 was not an independent risk factor for AKI in our study, but was still a risk factor for 3-year death and progressive CKD. The senescent kidney already shares morphological features of CKD [7], and the weighing of aging was heavier than eGFR in a multivariate regression analysis, which may explain the result.

However, most studies about preoperative renal dysfunction usually studied patients with eGFR < 60 mL/min /1.73 m2 [6, 14], but the risk of patients with mild decreased eGFR (60~90 mL/min /1.73 m2) and normal SCr is less evaluated. In the study by Howell et al. including 7621 consecutive patients who underwent CABG, valve surgery or combined procedures, eGFR ≥  90 mL/min /1.73 m2 were considered normal renal function (reference group), eGFR 60–90 mL/min/1.73 m2 were mild renal dysfunction (group 2), eGFR 30–59 mL/min/ 1.73 m2 were moderate renal dysfunction (group 3) and eGFR 15–29 mL/min/1.73 m2 were severe renal dysfunction (group 4) and the results showed that eGFR of 60–90 mL/min/1.73 m2 (mild renal dysfunction) was an independent predictor of in-hospital and late mortality as well as cardiovascular complications [15], which is in line with our results, which revealed that for patients with normal SCr under the age of 65 years preoperative 60 ≤ eGFR< 90 mL/min/1.73 m2 values became a risk factor for 3-year progressive CKD.

The mechanism why mild renal dysfunction contributes to poor outcomes is not clear. A possible explanation is that patients with impaired eGFR may have a more advanced cardiovascular disease and a reduced cardiac output before surgery. Along with aging, inflammatory mediators, endothelial dysfunction, left ventricular hypertrophy, all factors may contribute to the poor outcomes [16] and when eGFR values decreased to 60~90 mL/min/1.73 m2, it may be not obvious yet for the kidney to develop AKI, but the kidneys may be less able to recover from the injurious event of surgery.

The cause of preoperative decreased eGFR is complicated and different for eGFR 60~90 mL/min/1.73 m2 and eGFR < 60 mL/min/1.73 m2 cases. For patients with eGFR 60~90 mL/min/1.73 m2, aging and increased BMI may be the main causes for decreased eGFR [7, 17, 18]. In patients over the age of 65 years, the proportion of hidden renal dysfunction was up to 67.0% in our study. It is considered that intimal thickening and decreased compliance of the renal vasculature contribute to observed 10% decreases in renal blood flow (RBF) per decade of life [19] and a decline in eGFR has been observed in patients without histological evidence of nephrosclerosis [20]. Also our results showed that though the rate of abnormalities in urinalysis and renal ultrasound was significantly higher in the eGFR < 60 mL/min/1.73 m2 group, there was no statistical difference between 60 ≤ eGFR < 90 mL/min/1.73 m2 and no renal dysfunction cases, which confirmed that most patients with eGFR 60–90 mL/min/1.73 m2 have no substantial damage. However, 44.0% of our patients < 65 years old had hidden renal dysfunctions. Besides age-dependent changes in kidney structure and function, increased exposure to comorbidities including cardiac-renal syndrome (type II, IV), hypertension, diabetes and nephrotoxic drugs may together increase the susceptibility of the kidney to develop AKI. The main cause may be the hemodynamic instability caused by cardiac-renal syndrome, since in our study, the proportion of New York Heart Association (NYHA) > II of the other three groups were significantly higher than in the no renal dysfunction group. Proportions of hypertension and diabetes also increased along with the decreased eGFR. Thus non-age dependent hidden renal dysfunction may be functional and reversible, and efforts could be made for better prevention of AKI.

Our study has some limitations. First, it was an observational and retrospective study in a single center, possibly not able to identify all potential confounding factors. Furthermore, mild renal dysfunction is always poorly defined. Our study used the cut-off of SCr ≤ 1.2 mg/dL (female)/1.5 mg/dL (male) which was arbitrarily chosen from the normal value of our hospital. We chose it because our aim was to raise the awareness of surgeons to concern about patients with conventionally regarded normal SCr but decreased eGFR,

Conclusions

Known renal dysfunction (eGFR < 60 mL/min/1.73 m2) was a significant risk factor of progressive CKD for both ≥65 and < 65 year old patients. However, hidden renal dysfunction (60 ≤ eGFR < 90 mL/min/1.73 m2) correlated with progressive CKD only in < 65 year old patients. Awareness should be raised for these patient group.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AKI:

Acute kidney injury

BMI:

Body mass index

BUN:

Blood urea nitrogen

CABG:

Coronary artery bypass grafting

CKD:

Chronic kidney disease

CPB:

Cardiopulmonary bypass

DM:

Diabetes mellitus

eCrCl:

estimated creatinine clearance

eGFR:

estimated glomerular filtration rate

ICU:

Intensive care unit

LVEF:

Left ventricular ejection fraction

NYHA:

New York Heart Association

OPCAB:

Off-pump coronary artery bypass

PCr:

Plasma creatinine

RBF:

Renal blood flow

RRT:

Renal replacement therapy

SCr:

Serum creatinine

References

  1. Mao H, Katz N, Ariyanon W, Blanca-Martos L, Adybelli Z, Giuliani A, et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med. 2013;3(3):178–99.

    Article  Google Scholar 

  2. Boyle JM, Moualla S, Arrigain S, Worley S, Bakri MH, Starling RC, et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis. 2006;48(5):787–96.

    Article  Google Scholar 

  3. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162–8.

    Article  Google Scholar 

  4. Miceli A, Bruno VD, Capoun R, Romeo F, Angelini GD, Caputo M. Occult renal dysfunction: a mortality and morbidity risk factor in coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg. 2011;141(3):771–6.

    Article  Google Scholar 

  5. Marui A, Okabayashi H, Komiya T, Tanaka S, Furukawa Y, Kita T, et al. Impact of occult renal impairment on early and late outcomes following coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2013;17(4):638–43.

    Article  Google Scholar 

  6. Volkmann MA, Behr PE, Burmeister JE, Consoni PR, Kalil RA, Prates PR, et al. Hidden renal dysfunction causes increased in-hospital mortality risk after coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011;26(3):319–25.

    Article  Google Scholar 

  7. Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419–28.

    PubMed  PubMed Central  Google Scholar 

  8. Group KDIgoKakiw. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.

    Article  Google Scholar 

  9. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

    Google Scholar 

  10. Maganti MD, Rao V, Borger MA, Ivanov J, David TE. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation. 2005;112(9 Suppl):I448–52.

    PubMed  Google Scholar 

  11. Palomba H, de Castro I, Neto AL, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72(5):624–31.

    Article  CAS  Google Scholar 

  12. Jiang W, Teng J, Xu J, Shen B, Wang Y, Fang Y, et al. Dynamic predictive scores for cardiac surgery-associated acute kidney injury. J Am Heart Assoc. 2016;5(8):e003754.

    PubMed  PubMed Central  Google Scholar 

  13. Wijeysundera DN, Karkouti K, Beattie WS, Rao V, Ivanov J. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology. 2006;104(1):65–72.

    Article  Google Scholar 

  14. Zakeri R, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation. 2005;112(9 Suppl):I270–5.

    PubMed  Google Scholar 

  15. Howell NJ, Keogh BE, Bonser RS, Graham TR, Mascaro J, Rooney SJ, et al. Mild renal dysfunction predicts in-hospital mortality and post-discharge survival following cardiac surgery. Eur J Cardiothorac Surg. 2008;34(2):390–5.

    Article  Google Scholar 

  16. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107(1):87–92.

    Article  CAS  Google Scholar 

  17. Kanasaki K, Kitada M, Koya D. Pathophysiology of the aging kidney and therapeutic interventions. Hypertens Res. 2012;35:1121.

    Article  Google Scholar 

  18. Martensson J, Bellomo R. Prevention of renal dysfunction in postoperative elderly patients. Curr Opin Crit Care. 2014;20(4):451–9.

    Article  Google Scholar 

  19. Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol. 2011;119(Suppl 1):1–p5.

    Article  Google Scholar 

  20. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152(9):561–7.

    Article  Google Scholar 

Download references

Acknowledgments

None.

Funding

This work was supported by the Science and Technology Commission of Shanghai Municipality (Grant no. 17140902300), Shanghai Key Laboratory of Kidney and Blood Purification (Grant no. 14DZ2260200), Shanghai Shenkang Hospital Development Center New Frontier Technology Joint Project (Grant no. SHDC12018127) and the Xiamen Science and Technology Plan in 2018 (Grant no. 3502Z20184009). The funder had no role in the design of the study and collection, analysis, and interpretation of data, in writing the manuscript of the manuscript and in the decision to submit the article for publication.

Author information

Author notes

  1. Jiarui Xu and Jiawei Yu are first co-authors.

Authors and Affiliations

  1. Department of Nephrology, Zhongshan Hospital, Shanghai Medical College, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China

    Jiarui Xu, Jiawei Yu, Xialian Xu, Bo Shen, Yimei Wang, Wuhua Jiang, Wenlv Lv, Yi Fang, Jie Teng & Xiaoqiang Ding

  2. Shanghai Medical Center of Kidney, No. 180 Fenglin Road, Shanghai, 200032, China

    Jiarui Xu, Jiawei Yu, Xialian Xu, Bo Shen, Yimei Wang, Wuhua Jiang, Wenlv Lv, Yi Fang, Jie Teng & Xiaoqiang Ding

  3. Shanghai Institute for Kidney and Dialysis, No. 180 Fenglin Road, Shanghai, 200032, China

    Jiarui Xu, Jiawei Yu, Xialian Xu, Bo Shen, Yimei Wang, Wuhua Jiang, Wenlv Lv, Yi Fang, Jie Teng & Xiaoqiang Ding

  4. Shanghai Key Laboratory of Kidney and Blood Purification, No. 180 Fenglin Road, Shanghai, 200032, China

    Jiarui Xu, Jiawei Yu, Xialian Xu, Bo Shen, Yimei Wang, Wuhua Jiang, Wenlv Lv, Yi Fang, Jie Teng & Xiaoqiang Ding

  5. Hemodialysis Quality of Control Center of Shanghai, No. 180 Fenglin Road, Shanghai, 200032, China

    Yi Fang, Jie Teng & Xiaoqiang Ding

  6. Department of Critical Care Medicine, Zhongshan Hospital, Shanghai Medical College, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China

    Zhe Luo

  7. Department of Cardiovascular Surgery, Zhongshan Hospital, Shanghai Medical College, Fudan University, No. 180 Fenglin Road, Shanghai, 200032, China

    Chunsheng Wang

  8. Department of Nephrology, Xiamen Branch, Zhongshan Hospital, Fudan University, No. 668 Jinhu Road, Xiamen, 361015, Fujian, China

    Jie Teng & Xiaoqiang Ding

Authors
  1. Jiarui Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jiawei Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xialian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yimei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wuhua Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wenlv Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yi Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhe Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Chunsheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jie Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xiaoqiang Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JX, JY, XX, BS, YF, ZL, CW, XD and JT were responsible for the conception and design of the study. JX, JY, XX, BS, YW, WJ, WL and ZL were responsible for analysis of data; furthermore, JX, WJ and WL were in charge of statistical analysis. JX, JY and XX drafted the manuscript; YF, ZL, CW, XD and JT revised and commented the draft. All authors read and approved the final version of the manuscript.

Corresponding authors

Correspondence to Jie Teng or Xiaoqiang Ding.

Ethics declarations

Ethics approval and consent to participate

The Ethical Committee of Zhongshan Hospital affiliated to Fudan University approved the study (No. B2017–039) and written informed consent was obtained from all patients and our study was performed in accordance with the Declaration of Helsinki regarding the ethical principles for medical research involving human subjects.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Yu, J., Xu, X. et al. Preoperative hidden renal dysfunction add an age dependent risk of progressive chronic kidney disease after cardiac surgery. J Cardiothorac Surg 14, 151 (2019). https://doi.org/10.1186/s13019-019-0977-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13019-019-0977-9

Keywords

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us